Rezvilutamide plus docetaxel in chemotherapy‐naive metastatic castration‐resistant prostate cancer patients after progression on abiraterone: A multi‐centre, open‐label, phase II trial.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Liu, Zhenhua¹ (AUTHOR); Chen, Bo¹ (AUTHOR); Dai, Tao² (AUTHOR); Jiang, Shusuan² (AUTHOR); Luo, Hong³ (AUTHOR); Liao, Hong⁴ (AUTHOR); Yu, Dexin⁵ (AUTHOR); Chen, Zhiwen⁶ (AUTHOR); Zhang, Dahong⁷ (AUTHOR); Li, Zeng⁴ (AUTHOR); Zhang, Zhiqiang⁵ (AUTHOR); Bai, Hong⁷ (AUTHOR); Liu, Feng⁸ (AUTHOR); Lin, Jiaqin⁹ (AUTHOR); Wang, Yike¹⁰ (AUTHOR); Feng, Ping¹¹ (AUTHOR) ; Wei, Qiang¹ (AUTHOR)
المصدر:
Clinical & Translational Medicine. Apr2026, Vol. 16 Issue 4, p1-13. 13p.